Search

everythinglearnresearchcommunity

for

Search:↓

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Stress can cause hair loss and trigger autoimmunity by damaging hair follicle cells.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Celiac disease requires more than just a gluten-free diet for effective management.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Nanotechnology can improve tissue healing by controlling immune responses.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

Activating TRPV1 can boost hair growth by involving neurons, macrophages, and fibroblasts.

NFAT5 triggers atherosclerosis under stress by activating inflammation in blood vessels.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.